Postpartum Hemorrhage [clinicaltrials_resource:bbb8dbec9ede7c45edfcb563efdadd56]
RCT of Misoprostol for Postpartum Hemorrhage in India [clinicaltrials:NCT00097123]Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-Scheduled Cesarean Section [clinicaltrials:NCT00107874]clinicaltrials:NCT00116350Misoprostol in the Treatment of Postpartum Hemorrhage [clinicaltrials:NCT00116480]clinicaltrials:NCT00120042Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan [clinicaltrials:NCT00120237]Misoprostol for Preventing Postpartum Hemorrhage [clinicaltrials:NCT00124540]Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section? [clinicaltrials:NCT00257803]rhuFVIIa in Post-partum Hemorrhage [clinicaltrials:NCT00370877]clinicaltrials:NCT00462839Active Versus Expectant Management of the Third Stage of Labor [clinicaltrials:NCT00473707]clinicaltrials:NCT00781066clinicaltrials:NCT00790062Impact of Uterotonic Agents on Isolated Human Myometrium [clinicaltrials:NCT00989027]clinicaltrials:NCT01080846Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana [clinicaltrials:NCT01108289]Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India [clinicaltrials:NCT01108302]Non-Invasive Measurement of Hemoglobin (Using Pulse Co-Oximetry) in Patients Undergoing Elective Cesarean Delivery [clinicaltrials:NCT01108471]Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage [clinicaltrials:NCT01180192]Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? [clinicaltrials:NCT01252342]Carbetocin at Elective Cesarean Delivery [clinicaltrials:NCT01262742]Emergency Peripartum Hysterectomy: A Prospective Study in Iran [clinicaltrials:NCT01285258]Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin [clinicaltrials:NCT01373359]Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia [clinicaltrials:NCT01382732]Carbetocin at Elective Cesarean Delivery Part 2 [clinicaltrials:NCT01428817]Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India [clinicaltrials:NCT01462422]Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali [clinicaltrials:NCT01487278]clinicaltrials:NCT01497756A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso) [clinicaltrials:NCT01510574]clinicaltrials:NCT01579201clinicaltrials:NCT01600612Intravenous and Intramuscular Administration of Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage [clinicaltrials:NCT01608958]Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in Egypt [clinicaltrials:NCT01619072]Carbetocin at Elective Cesarean Delivery Part 3 [clinicaltrials:NCT01651130]clinicaltrials:NCT01665456Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment [clinicaltrials:NCT01689298]In Vitro Myometrial Contractions in Laboring and Non-laboring Women [clinicaltrials:NCT01689311]HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency [clinicaltrials:NCT01701947]Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities [clinicaltrials:NCT01710566]Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal [clinicaltrials:NCT01713153]
condition [clinicaltrials_vocabulary:condition]
RCT of Misoprostol for Postpartum Hemorrhage in India [clinicaltrials:NCT00097123]Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-Scheduled Cesarean Section [clinicaltrials:NCT00107874]clinicaltrials:NCT00116350Misoprostol in the Treatment of Postpartum Hemorrhage [clinicaltrials:NCT00116480]clinicaltrials:NCT00120042Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan [clinicaltrials:NCT00120237]Misoprostol for Preventing Postpartum Hemorrhage [clinicaltrials:NCT00124540]Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section? [clinicaltrials:NCT00257803]Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks [clinicaltrials:NCT00344929]rhuFVIIa in Post-partum Hemorrhage [clinicaltrials:NCT00370877]clinicaltrials:NCT00462839Active Versus Expectant Management of the Third Stage of Labor [clinicaltrials:NCT00473707]Carbetocin Versus Syntometrine for the Third Stage of Labour [clinicaltrials:NCT00499005]clinicaltrials:NCT00781066clinicaltrials:NCT00790062clinicaltrials:NCT00872469Haemorrhagia Postpartum: an Implementation Study on the NVOG Guidelines and MOET Instructions [clinicaltrials:NCT00928863]Impact of Uterotonic Agents on Isolated Human Myometrium [clinicaltrials:NCT00989027]Prevention of Post-partum Haemorrhage [clinicaltrials:NCT01044082]clinicaltrials:NCT01080846clinicaltrials:NCT01085006Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana [clinicaltrials:NCT01108289]Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India [clinicaltrials:NCT01108302]Non-Invasive Measurement of Hemoglobin (Using Pulse Co-Oximetry) in Patients Undergoing Elective Cesarean Delivery [clinicaltrials:NCT01108471]clinicaltrials:NCT01113229Intrarectal Misoprostol in Postpartum Haemorrhage [clinicaltrials:NCT01116050]Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage [clinicaltrials:NCT01180192]Oxytocin in Cesarean Delivery [clinicaltrials:NCT01236482]Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? [clinicaltrials:NCT01252342]Carbetocin at Elective Cesarean Delivery [clinicaltrials:NCT01262742]Emergency Peripartum Hysterectomy: A Prospective Study in Iran [clinicaltrials:NCT01285258]clinicaltrials:NCT01359878Balloon Catheters in Cases of Abnormal Placentation [clinicaltrials:NCT01373255]Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin [clinicaltrials:NCT01373359]Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations [clinicaltrials:NCT01373801]Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia [clinicaltrials:NCT01382732]Carbetocin at Elective Cesarean Delivery Part 2 [clinicaltrials:NCT01428817]Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India [clinicaltrials:NCT01462422]Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE) [clinicaltrials:NCT01480544]clinicaltrials:NCT01485562
condition browse [clinicaltrials_vocabulary:condition-browse]
RCT of Misoprostol for Postpartum Hemorrhage in India [clinicaltrials:NCT00097123]Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-Scheduled Cesarean Section [clinicaltrials:NCT00107874]clinicaltrials:NCT00116350Misoprostol in the Treatment of Postpartum Hemorrhage [clinicaltrials:NCT00116480]clinicaltrials:NCT00120042Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan [clinicaltrials:NCT00120237]Misoprostol for Preventing Postpartum Hemorrhage [clinicaltrials:NCT00124540]Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section? [clinicaltrials:NCT00257803]Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks [clinicaltrials:NCT00344929]rhuFVIIa in Post-partum Hemorrhage [clinicaltrials:NCT00370877]clinicaltrials:NCT00462839Active Versus Expectant Management of the Third Stage of Labor [clinicaltrials:NCT00473707]Carbetocin Versus Syntometrine for the Third Stage of Labour [clinicaltrials:NCT00499005]clinicaltrials:NCT00781066clinicaltrials:NCT00790062clinicaltrials:NCT00872469Haemorrhagia Postpartum: an Implementation Study on the NVOG Guidelines and MOET Instructions [clinicaltrials:NCT00928863]Impact of Uterotonic Agents on Isolated Human Myometrium [clinicaltrials:NCT00989027]Prevention of Post-partum Haemorrhage [clinicaltrials:NCT01044082]clinicaltrials:NCT01080846clinicaltrials:NCT01085006Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana [clinicaltrials:NCT01108289]Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India [clinicaltrials:NCT01108302]Non-Invasive Measurement of Hemoglobin (Using Pulse Co-Oximetry) in Patients Undergoing Elective Cesarean Delivery [clinicaltrials:NCT01108471]clinicaltrials:NCT01113229Intrarectal Misoprostol in Postpartum Haemorrhage [clinicaltrials:NCT01116050]Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage [clinicaltrials:NCT01180192]Oxytocin in Cesarean Delivery [clinicaltrials:NCT01236482]Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? [clinicaltrials:NCT01252342]Carbetocin at Elective Cesarean Delivery [clinicaltrials:NCT01262742]Emergency Peripartum Hysterectomy: A Prospective Study in Iran [clinicaltrials:NCT01285258]clinicaltrials:NCT01359878Balloon Catheters in Cases of Abnormal Placentation [clinicaltrials:NCT01373255]Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin [clinicaltrials:NCT01373359]Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations [clinicaltrials:NCT01373801]Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia [clinicaltrials:NCT01382732]Carbetocin at Elective Cesarean Delivery Part 2 [clinicaltrials:NCT01428817]Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India [clinicaltrials:NCT01462422]Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE) [clinicaltrials:NCT01480544]clinicaltrials:NCT01485562
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Postpartum Hemorrhage [clinicaltrials_resource:bbb8dbec9ede7c45edfcb563efdadd56]
Bio2RDF identifier
bbb8dbec9ede7c45edfcb563efdadd56
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bbb8dbec9ede7c45edfcb563efdadd56
identifier
clinicaltrials_resource:bbb8dbec9ede7c45edfcb563efdadd56
title
Postpartum Hemorrhage
@en
type
label
Postpartum Hemorrhage [clinicaltrials_resource:bbb8dbec9ede7c45edfcb563efdadd56]
@en
Postpartum Hemorrhage